Helen Dakin
Research groups
Colleges
Helen Dakin
MSc DPhil
Senior Researcher
Helen Dakin joined the Health Economics Research Centre in February 2008. Before starting at HERC, she worked at Abacus International and completed her MSc in Economic Evaluation in Healthcare at City University. She previously graduated from Cambridge University with Masters and Bachelor's degrees in Biochemistry. In 2014, she completed a DPhil at the University of Oxford on the optimal methods for conducting economic evaluations of factorial clinical trials.
Her current projects include: the STAR trial, which evaluates radiotherapy alongside bevacizumab (Avastin) in age-related macular degeneration; the ACHE study, which evaluates clinical tools and thresholds for selecting patients for joint replacement; and the KAT trial, which assesses the cost-effectiveness of different types of knee replacement component.
Research paper on factors influencing NICE decisions available here.
Recent publications
-
Statistical and Health Economic Analysis Plan for a Randomized Controlled trial of Surgical Fixation with K-Wires versus Plaster Casting in the Treatment of Dorsally Displaced Distal Radius Fractures: DRAFFT2
OOMS A. et al, (2020), Bone and Joint Open
-
Economic evaluation of factorial trials: cost-utility analysis of the AFORRD 2x2x2 factorial trial of atorvastatin, omega-3 fish oil and action-planning
DAKIN H. et al, (2020), Value in Health
-
Which interactions matter in economic evaluations?
A systematic review and simulation study
DAKIN H. and GRAY A., (2020), BMC Medical Research Methodology
-
Which interactions matter in economic evaluations? A systematic review and simulation study
Dakin HA. and Gray A., (2020)
-
Which interactions matter in economic evaluations? A systematic review and simulation study
Dakin H. and Gray A., (2020)